EcoDrugPlus

Ensembl ID : ENSOMYG00000038167
Gene Symbol: -
Cross references: -
229 Possible Orthologues:

Ensembl ID : ENSOMYG00000033799
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSOMYG00000030929
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSOMYG00000033863
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSOMYG00000028423
Gene Symbol: -
Cross references: -
166 Possible Orthologues:

Ensembl ID : ENSOMYG00000034004
Gene Symbol: -
Cross references: -
178 Possible Orthologues:

Ensembl ID : ENSOMYG00000027138
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSOMYG00000027111
Gene Symbol: -
Cross references: -
166 Possible Orthologues:

Ensembl ID : ENSOMYG00000034299
Gene Symbol: -
Cross references: -
242 Possible Orthologues:

Ensembl ID : ENSOMYG00000034641
Gene Symbol: -
Cross references: -
213 Possible Orthologues:

Ensembl ID : ENSOMYG00000034698
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSOMYG00000034900
Gene Symbol: -
Cross references: -
373 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).